Page 2069 - Williams Hematology ( PDFDrive )
P. 2069

2044           Part XII:  Hemostasis and Thrombosis                                                                                                               Chapter 120:  Hereditary Qualitative Platelet Disorders        2045




               not occur normally, the very small amount of residual integrin α  will   Of note, many of the patients with identified mutations are compound
                                                              IIb
                                   53
               be pro-α , not mature α .  Pro-α  has been reported to bind to the   heterozygotes rather than homozygotes, indicating that a sizable num-
                                 IIb
                      IIb
                                         IIb
               membrane-bound endoplasmic reticulum chaperone calnexin, provid-  ber of silent carriers are present in the population. Where consanguinity
               ing a potential mechanism for assessing whether the protein has under-  is common, the disorder is more likely to be caused by a homozygous
               gone proper folding (calnexin cycle) and perhaps explaining how the   mutation arising in a founder, but even under these circumstances, more
               receptor adopts a bent configuration. 54,55            than one mutation may be present. Thus, in the Iraqi-Jewish population,
                   Integrin  β   (GPIIIa)  can  also  combine  with  the  integrin  α     in which consanguinity has been present from 586 bce to the present,
                           3
                                                                  V
                                                                                                                        39
               (CD51) subunit to form the integrin α β  “vitronectin” receptor 30,56,57    two separate mutations have been identified in more than one family.
                                            V 3
               (see Fig. 120–2; Chap. 112). This receptor can bind many of the same   Most of the missense mutations result in decreased expression of integ-
               adhesive glycoproteins as integrin α β , although there are some dif-  rin α β  on the surface of platelets. This probably reflects the stringent
                                          IIb 3
                                                                          IIb 3
               ferences in ligand preference and binding sequences. 57–61  A small num-  structural requirements for proper folding and complex formation.
               ber of integrin α β  receptors are present on platelets (50 to 100 per   Mutations in Integrin α β  Within the Metal Ion-Dependent
                                                                                            IIb 3
                            V 3
               platelet) 60,62,63 ; osteoclasts, endothelial cells, macrophages, vascular   Adhesion Site of Integrin β  and the Interface with the Integrin α
                                                                                                                        IIb
                                                                                           3
               smooth muscle, and uterine cells, among others, also have integrin α β    β-Propeller  A metal coordination site or MIDAS domain, which is
                                                                V 3
               receptors. 64,65  In general, GT patients with defects in integrin β  also   highly conserved in six integrin receptor α-chain subunits and required
                                                              3
               are deficient in integrin α β , whereas patients with defects in integrin   for ligand-binding, is also present in the β-A (or I-like) domain of the
                                  V 3
               α  have either normal or increased numbers of platelet integrin α β    integrin  β  subunit.  Mutagenesis and molecular modeling experi-
                                                                                     72
                IIb
                                                                              3
                                                                V 3
               receptors. 60,63,64,66–68  One exception to this rule is a patient with a defect   ments suggested that a highly conserved DxSxS amino acid sequence
                                                                                                                        73
               in β  (H280P) that interferes with integrin α β  biogenesis to a much   motif plus additional coordinating residues are brought together in the
                                                IIb 3
                  3
               greater extent than integrin α β  biogenesis.  At present, there is no   three-dimensional structure of the β  subunit to form a cation-binding
                                                69
                                                                                                3
                                     V 3
                                                                                             74
               evidence that patients who lack integrin α β  receptors in addition to   sphere of the MIDAS domain,  and this was confirmed by the crys-
                                              V 3
               lacking integrin α β  receptors have a more-severe hemorrhagic diath-  tal structures of integrin α β  and later integrin α β  (see Chap. 112,
                                                                                                           IIb 3
                            IIb 3
                                                                                         V 3
               esis or suffer from any other abnormalities, perhaps because alternative   Fig. 112–111, and Fig. 120–3). 75,76  Thus, the β  MIDAS is composed
                                                                                                        3
                                                                                     123
                                                                           119
                                                                                                   251
                                                                                121
               receptors containing integrin α  associated with other β subunits can   of Asp , Ser , Ser , Glu , and Asp . A region originally termed
                                                                                          220
                                      V
                                    63
                                                                                                                     77
               substitute for integrin α β .  Upregulation of integrin α β  on osteo-  the ligand-associated metal binding site (LIMBS) in integrin α β ,  but
                                                                                                                   V 3
                                                         2 1
                                 V 3
                                                                                                                        78
               clasts of Iraqi-Jewish patients with GT has been reported as a potential   now termed the synergy metal binding site (SyMBS) in integrin α β ,
                                                                                                                     IIb 3
               compensatory mechanism to explain the lack of bone changes despite   binds a Ca  ion and is required for binding of ligands to the MIDAS. It
                                                                              2+
               the deficiency in osteoclast integrin α β . 70         is composed of atoms from D158, N215, D217, P219, and E220. Integrin
                                          V 3
                   The molecular biologic abnormalities in more than 100 patients   β  residues 214 and 216 are in close proximity with both the SyMBS
                                                                       3
               with GT have been identified and they are listed in an internet database   residues and the interface with the α  subunit. Adjacent to the MIDAS
                                                                                                IIb
               that is updated continuously  (http://med.mssm.edu/glanzmanndb).   domain is a metal ion site termed the ADMIDAS (adjacent to metal
                                     71
               Figure 120–3 contains information on mutations of particular interest.   ion-dependent  adhesion  site),  in  which  calcium  is  coordinated  by
                                     6                                   Figure 120–3.  Diagram of  α β  structure and identification of
                                2        3                               select mutations causing Glanzmann thrombasthenia.  The web-
                                                                                                IIb 3
                                                                         site  http://med.mssm.edu/glanzmanndb  contains  a full  listing of
                                            2
                                                                         reported Glanzmann thrombasthenia mutations. The  α β  struc-
                                                                                                                  IIb 3
                       7                                                 ture depicted is a composite of data from crystal and NMR struc-
                                                                         tures, as well as molecular modeling of missing regions. Among
                                                                         the missense mutations identified are ones that (1) interfere with
                                                                         inside-out and outside-in signaling (β  S752P); (2) interfere with
                                                                                                     3
                                                                         ligand binding to either the metal ion-dependent adhesion site
                                    5                                    (MIDAS) in β  (β  D119Y and D119N) or the α  component of the
                                                                                  3
                                                                                                          IIb
                                                                                     3
                                                                         ligand binding site (Y143H, P145L/A, insert R160/T161); (3) result in
                                                                         receptors that are sensitive to dissociation by divalent cation chela-
                                                                         tion (β  R214W, R214Q, R216Q); (4) result in a constitutively active
                                                                              3
                                                                         receptor (β  C560R); (5) alter the interface between α  and β  and
                                                                                                                     3
                                                                                 3
                                                                                                                IIb
                                                          4              disrupt ligand binding (β  L262Y); (6) result in a β  protein that can
                                                                                                            3
                                                                                           3
                                                                         complex more effectively with αV than α  (S162L, R216Q, H280P);
                                                                                                       IIb
                                                                         or  (7)  alter  the  α   propeller  structure  and  prevent  normal  α β
                                                                                                                       IIb 3
                                                                                      IIb
                                                                         complex formation, processing, and/or transport. The mutations
                                                                         identified by number 8 in α  (G991C and R995Q/W) and β  (L718P
                                                                                                                   3
                                                                                             IIb
                                                                         and D723H) are gain-of-function mutations associated with macro/
                                                                         anisothrombocytopenia. (Reproduced with permission from Dr. Ana
                                                                         Negri based on PDBids 3FCS, 3G9W, 2K9J, 2KNC, and 2KV9 and molec-
                                                                         ular modeling of the missing segments of the α  calf domain, the β3
                                                                                                          IIb
                                                                         hybrid domain, and the link between the β3 EGF-1 and EGF-2 domains.)
                                   8                8
                                                                      8
          Kaushansky_chapter 120_p2039-2072.indd   2044                                                                 9/21/15   2:20 PM
   2064   2065   2066   2067   2068   2069   2070   2071   2072   2073   2074